Bannen; Lynne Canne
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bannen; Lynne Canne.The latest application filed is for "compounds for the treatment of kinase-dependent disorders".
Company Profile
5.19.33
- Bannen; Lynne Canne - Novato CA
- Bannen; Lynne Canne - New Castle IN
- Bannen; Lynne Canne - Pacifica CA
- Bannen; Lynne Canne - Lucerne CA
- Bannen; Lynne Canne - Luceme CA
Patent Activity
| Patent | Date |
|---|---|
| Compounds for the Treatment of Kinase-Dependent Disorders App 20220089541 - Bannen; Lynne Canne ; et al. | 2022-03-24 |
| C-met modulators and methods of use Grant 11,124,482 - Bannen , et al. September 21, 2 | 2021-09-21 |
| C-met Modulators And Methods Of Use App 20210253530 - Bannen; Lynne Canne ; et al. | 2021-08-19 |
| Compounds for the Treatment of Kinase-Dependent Disorders App 20210040099 - Bannen; Lynne Canne ; et al. | 2021-02-11 |
| Compounds for the Treatment of Kinase-Dependent Disorders App 20210040076 - Bannen; Lynne Canne ; et al. | 2021-02-11 |
| Compounds for the Treatment of Kinase-Dependent Disorders App 20210032263 - Bannen; Lynne Canne ; et al. | 2021-02-04 |
| C-Met Modulators and Methods of Use App 20200331860 - Bannen; Lynne Canne ; et al. | 2020-10-22 |
| ROR.gamma. modulators Grant 10,035,790 - Xu , et al. July 31, 2 | 2018-07-31 |
| C-Met Modulators and Methods of Use App 20170355678 - Bannen; Lynne Canne ; et al. | 2017-12-14 |
| c-Met Modulators and Method of Use App 20160185725 - Bannen; Lynne Canne ; et al. | 2016-06-30 |
| C-Met Modulators and Methods of Use App 20150376133 - Bannen; Lynne Canne ; et al. | 2015-12-31 |
| c-Met modulators and methods of use Grant 9,174,947 - Bannen , et al. November 3, 2 | 2015-11-03 |
| Methods of Using C-Met Modulators App 20150202196 - Bannen; Lynne Canne ; et al. | 2015-07-23 |
| Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 8,889,664 - Bajjalieh , et al. November 18, 2 | 2014-11-18 |
| Human Adam-10 Inhibitors App 20140206865 - Bannen; Lynne Canne ; et al. | 2014-07-24 |
| c-Met Modulators and Method of Use App 20140155378 - Bannen; Lynne Canne ; et al. | 2014-06-05 |
| C-Met Modulators and Method of Use App 20140155396 - Bannen; Lynne Canne ; et al. | 2014-06-05 |
| c-Met Modulators and Method of Use App 20130252940 - Bannen; Lynne Canne ; et al. | 2013-09-26 |
| C-met modulators and method of use Grant 8,497,284 - Bannen , et al. July 30, 2 | 2013-07-30 |
| c-Met modulators and method of use Grant 8,476,298 - Bannen , et al. July 2, 2 | 2013-07-02 |
| Human Adam-10 Inhibitors App 20130144056 - Bannen; Lynne Canne ; et al. | 2013-06-06 |
| C-Met Modulators and Method of Use App 20120184523 - Bannen; Lynne Canne ; et al. | 2012-07-19 |
| c-Met modulators and method of use Grant 8,178,532 - Bannen , et al. May 15, 2 | 2012-05-15 |
| Human Adam-10 Inhibitors App 20120071653 - Bannen; Lynne Canne ; et al. | 2012-03-22 |
| Methods of Using C-Met Modulators App 20120070368 - Bannen; Lynne Canne ; et al. | 2012-03-22 |
| C-Met Modulators and Method of Use App 20120022065 - Bannen; Lynne Canne ; et al. | 2012-01-26 |
| Kinase modulators and methods of use Grant 8,076,338 - Anand , et al. December 13, 2 | 2011-12-13 |
| c-Met modulators and methods of use Grant 8,067,436 - Bannen , et al. November 29, 2 | 2011-11-29 |
| Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use App 20110207712 - Bajjalieh; William ; et al. | 2011-08-25 |
| Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 7,989,622 - Bajjalieh , et al. August 2, 2 | 2011-08-02 |
| Human ADAM-10 inhibitors Grant 7,989,661 - Bannen , et al. August 2, 2 | 2011-08-02 |
| c-MET modulators and method of use Grant 7,977,345 - Bannen , et al. July 12, 2 | 2011-07-12 |
| C-Met Modulators and Method of Use App 20110077233 - Bannen; Lynne Canne ; et al. | 2011-03-31 |
| Modulators of S1P and Methods of Making And Using App 20100249071 - Bannen; Lynne Canne ; et al. | 2010-09-30 |
| Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use App 20100087440 - Bajjalieh; William ; et al. | 2010-04-08 |
| Human ADAM-10 inhibitors Grant 7,629,341 - Bannen , et al. December 8, 2 | 2009-12-08 |
| c-Met modulators and methods of use Grant 7,579,473 - Bannen , et al. August 25, 2 | 2009-08-25 |
| c-MET MODULATORS AND METHODS OF USE App 20090105299 - BANNEN; LYNNE CANNE ; et al. | 2009-04-23 |
| [1H-Pyrazolo[3, 4-D]Pyrimidin-4-Yl]-Piperidine or -Piperazine Compounds as Serine-Theoronine Kinase Modulators (P70s6k, Atk1 and Atk2) for the Treatment of Immunological, Inflammatory and Proliferative Diseases App 20080188482 - Rice; Ken ; et al. | 2008-08-07 |
| Kinase Modulators and Methods of Use App 20080076774 - Anand; Neel K. ; et al. | 2008-03-27 |
| Tie-2 Modulators and Methods of Use App 20070275952 - Bannen; Lynne Canne ; et al. | 2007-11-29 |
| c-MET MODULATORS AND METHOD OF USE App 20070244116 - BANNEN; LYNNE CANNE ; et al. | 2007-10-18 |
| C-met Modulators And Method Of Use App 20070225307 - Bannen; Lynne Canne ; et al. | 2007-09-27 |
| c-MET MODULATORS AND METHOD OF USE App 20070179130 - BANNEN; LYNNE CANNE | 2007-08-02 |
| c-Met modulators and methods of use App 20070054928 - Bannen; Lynne Canne ; et al. | 2007-03-08 |
| Human adam-10 inhibitors App 20060199820 - Bannen; Lynne Canne ; et al. | 2006-09-07 |
| General chemical ligation Grant 6,307,018 - Kent , et al. October 23, 2 | 2001-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 